Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

23.69 +0.15 (+0.64%)
Official Closing Price Updated: 7:00 PM EDT, Aug 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all seeing declines. 
Via Benzinga
Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More
The company is selling its Vantive Kidney Care business to Carlyle, a private equity investor in the medtech space. 
Via Investor's Business Daily
Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment
Baxter has agreed to sell its Kidney Care segment to Carlyle for $3.8 billion. Baxter will receive about $3.5 billion in cash, with net after-tax proceeds estimated at $3 billion. Post-sale, Baxter... 
Via Benzinga
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
From Baxter International Inc.
Via Business Wire
The Latest Analyst Ratings For Baxter Intl
 
Via Benzinga
Assessing Baxter Intl: Insights From 4 Financial Analysts
 
Via Benzinga
How Is The Market Feeling About Baxter Intl?
 
Via Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q2 2024
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Baxter Lifts Annual Outlook After Strong Q2 Beat, Medical Devices Sales
Baxter surpasses Q2 expectations with adjusted EPS of $0.68 and sales of $3.812 billion. Sales rose 3% reported and 4% constant currency, driven by Pharmaceuticals, Medical Products, and Healthcare... 
Via Benzinga
Baxter Reports Second-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
3 Contrarian Stock Picks to Buy Against the Market Consensus
Discover three contrarian stock picks with strong fundamentals that defy current market trends and offer significant rebound potential. 
Via InvestorPlace
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
Ares Management and HPS Investment Partners lead a $3 billion credit facility to support Carlyle's potential acquisition of Baxter's kidney-care division, highlighting the evolving role of private... 
Via Benzinga
Unveiling 5 Analyst Insights On Baxter Intl
 
Via Benzinga
(BAX) - Analyzing Baxter Intl's Short Interest
 
Via Benzinga
Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact
From Baxter International Inc.
Via Business Wire
3 Bargain Bin Stocks with Millionaire-Maker Potential
Three bargain stocks with substantial upside from potential price-to-earnings multiple reratings and accretive buybacks. 
Via InvestorPlace
Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit Vantive: Report
Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt. The deal reflects a significant move in private-equity dealmaking and... 
Via Benzinga
“Cash Flow Is The Name Of The Game” Stock Market
Liquidity is becoming a problem and the Fed (and other Central Bankers) know it. Higher for longer is a luxury they can no longer afford. 
Via Talk Markets
Topics Economy
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
7 Deeply Undervalued Stocks to Buy Now or Regret Later
Unlock massive upside by buying these deeply undervalued stocks at fire-sale prices. These companies have staying power and could bounce back. 
Via InvestorPlace
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
From Baxter International Inc.
Via Business Wire
3 Dividend Growth Stocks For Long-Term Returns
One way to measure the quality of a dividend stock is by its dividend history. Stocks with established histories of dividend growth may be likely to continue growing their dividends moving forward.... 
Via Talk Markets
Baxter to Present at Jefferies 2024 Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
 
Via Benzinga
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and... 
Via Benzinga
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
From Baxter International Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.